“In the last week of the quarter, we re-initiated a position in PTTEP TB (1.5%), a new holding in BCP TB (1.5%) and MEDC IJ (4.5%), increased our weighting in HIBI MK from 4% to 6%, and VEB MK from 3% to 5%, and exited PGAS IJ (2%) to fund these positions. Our timing proved...”
Each excerpt above is the manager's commentary on this ticker specifically. The full letter has the rest of their portfolio thinking, risk discussion, and broader institutional context.